Papillocare vaginal gel 21x5ml

Papillocare vaginal gel is a medical device designed to restore the epithelium of the transitional (transformation) zone of the cervix for the prevention and supportive treatment of lesions (mucosal injury) caused by HPV.

It creates a protective barrier in the cervical transition zone to prevent the risk of HPV attack. Improves the healing process if the gel is used as a supportive agent during the treatment of intraepithelial lesions caused by HPV on the mucous membrane of the cervix and vagina.

Papillocare is suitable:

• to control and restore the cervical transition zone epithelium for the prevention of HPV lesions (LSIL),
• supportive treatment of intraepithelial lesions caused by HPV,
• healing and promoting the restoration of the epithelium by lesions of the mucous membrane of the cervix and vagina,
• treatment of dryness of the mucous membrane of the cervix and vagina,
• restoring the balance of the vaginal microbiota,
• improvement of the health of the vagina,
• creating conditions for the rapid healing of lesions that have occurred due to burning or itching,
• the formation of a protective thin layer that quickly reduces irritation by creating suitable conditions for a natural healing process.

Intended for:

• women (over 18 years of age) infected with human papillomavirus (HPV), whether or not they already have lesions caused by the virus (ASCUS or LSIL).

Active ingredients: Hyaluronic acid niosomes, ß-glucan niosomes, Asian umbilical cord phytosomes, Coriolus versicolor extract, Zederach BioEcolia® extract, aloe vera extract, ingredients enabling the formation of the gel.

The package contains 21 single doses of 5 ml.